Nucleoporin p62 inhibitors are a specialized class of chemical compounds designed to target and disrupt the function of nucleoporin p62, an essential protein component of the nuclear pore complex (NPC). The NPC is a large and intricate structure that spans the nuclear envelope, acting as a gateway for the selective transport of molecules between the nucleus and the cytoplasm in eukaryotic cells. Nucleoporin p62, also known as Nup62, is a key constituent of the NPC and plays a critical role in regulating the transport of macromolecules such as proteins and nucleic acids. Inhibitors of nucleoporin p62 are developed to interfere with its normal function, thereby modulating the nucleocytoplasmic transport process, which can have profound implications for various cellular functions.
Chemically, nucleoporin p62 inhibitors are designed to bind specifically to nucleoporin p62 or its interacting partners within the NPC. By doing so, they disrupt the proper assembly and stability of the nuclear pore complex, leading to altered permeability and selectivity of the nuclear envelope. This disruption can result in the mislocalization of key cellular components, such as transcription factors and mRNA molecules, impacting gene expression and various cellular processes. Researchers study these inhibitors to gain insights into the fundamental mechanisms of nucleocytoplasmic transport and its regulation. Additionally, they may explore the use of nucleoporin p62 inhibitors as research tools to manipulate cellular processes for experimental purposes. Understanding the precise functions and interactions of nucleoporin p62 inhibitors can contribute to our knowledge of cell biology and reveals novel strategies for manipulating cellular processes in various fields of research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methylation inhibitor might alter the epigenetic status of the p62 gene, potentially leading to changes in its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it could affect the chromatin structure around the p62 gene, influencing its transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR inhibitor could potentially impact cellular pathways that indirectly regulate p62 expression or its associated functions. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
As an HSP90 inhibitor, it might affect the stability or function of proteins that interact with or regulate p62. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This proteasome inhibitor might alter the degradation rates of proteins involved in p62 regulation, indirectly affecting its levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, it could modulate signaling pathways that indirectly influence p62 expression. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
As a p38 MAPK inhibitor, it could alter signaling pathways involved in stress responses that might affect p62. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
A derivative of geldanamycin, this HSP90 inhibitor could similarly affect the stability of proteins regulating p62. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This MEK inhibitor could alter MAPK signaling, potentially leading to changes in p62 levels or activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, it might impact stress response pathways and subsequently affect p62 regulation. | ||||||